Investec, the South African banking group, is boosting its investment banking healthcare practice with the hiring of a life sciences team from Tucker Anthony Sutro Capital Markets.

Tucker Anthoy is being acquired by RBC Financial Group. The team moving to Investec will be headed by Roger Kahn, and it will focus on biotechnology, specialty pharmaceutical and medical device companies in the emerging-growth, middle-market sector. Last week, the firm added a Technology, Media, and Telecommunications team from UBS Warburg.

“The addition of Roger Kahn and his very high-caliber life sciences team expands the breadth and depth of our existing healthcare practice, which historically has had a well established healthcare services presence,” says Mark Segall, CEO of Investec PMG. “The team’s activities, which are truly international in reach, fit perfectly into our rapidly expanding global platform. This acquisition will allow us to be a serious full-service
investment banking adviser across the entire healthcare continuum.”